[1] NIEDERWERDER M C, BAWA B, SERAO N V, TRIBLE B R, KERRIGAN M A, LUNNEY J K, DEKKERS J C, ROWLAND R R. Vaccination with a porcine reproductive and respiratory syndrome (PRRS) modified live virus vaccine followed by challenge with PRRS virus and porcine circovirus type 2 (PCV2) protects against PRRS but enhances PCV2 replication and pathogenesis compared to results for nonvaccinated cochallenged controls. Clinical and Vaccine Immunology: CVI, 2015, 22(12): 1244-1254.
[2] WENSVOORT G, TERPSTRA C, POL J M, TER LAAK E A, BLOEMRAAD M, DE KLUYVER E P, KRAGTEN C, VAN BUITEN L, DEN BESTEN A, WAGENAAR F, ET AL. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Veterinary Quarterly, 1991, 13(3): 121-130.
[3] NELSEN C J, MURTAUGH M P, FAABERG K S. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. Journal of Virology, 1999, 73(1): 270-280.
[4] ALLENDE R, LEWIS T L, LU Z, ROCK D L, KUTISH G F, ALI A, DOSTER A R, OSORIO F A. North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. Journal of General Virology, 1999, 80(2): 307-315.
[5] WELLS K D, BARDOT R, WHITWORTH K M, TRIBLE B R, FANG Y, MILEHAM A, KERRIGAN M A, SAMUEL M S, PRATHER R S, ROWLAND R R R. Replacement of porcine CD163 scavenger receptor cysteine-rich domain 5 with a CD163-Like homolog confers resistance of pigs to genotype 1 but not genotype 2 porcine reproductive and respiratory syndrome virus. Journal of Virology, 2017, 91(2): e01521-01516.
[6] NEUMANN E J, KLIEBENSTEIN J B, JOHNSON C D, MABRY J W, BUSH E J, SEITZINGER A H, GREEN A L, ZIMMERMAN J J. Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. Journal of the American Veterinary Medical Association, 2005, 227(3): 385-392.
[7] ZHOU L, YANG H. Porcine reproductive and respiratory syndrome in China. Virus Research, 2010, 154(1-2): 31-37.
[8] JUSA E R, INABA Y, KOUNO M, HIROSE O. Effect of heparin on infection of cells by porcine reproductive and respiratory syndrome virus. American Journal of Veterinary Research, 1997, 58(5): 488-491.
[9] CALVERT J G, SLADE D E, SHIELDS S L, JOLIE R, MANNAN R M, ANKENBAUER R G, WELCH S K. CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses. Journal of Virology, 2007, 81(14): 7371-7379.
[10] VAN GORP H, DELPUTTE P L, NAUWYNCK H J. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell- directed therapy. Molecular Immunology, 2010, 47(7-8): 1650-1660.
[11] PATTON J B, ROWLAND R R, YOO D, CHANG K O. Modulation of CD163 receptor expression and replication of porcine reproductive and respiratory syndrome virus in porcine macrophages. Virus Research, 2009, 140(1-2): 161-171.
[12] VAN GORP H, VAN BREEDAM W, VAN DOORSSELAERE J, DELPUTTE P L, NAUWYNCK H J. Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus. Journal of Virology, 2010, 84(6): 3101-3105.
[13] WHITWORTH K M, ROWLAND R R, EWEN C L, TRIBLE B R, KERRIGAN M A, CINO-OZUNA A G, SAMUEL M S, LIGHTNER J E, MCLAREN D G, MILEHAM A J, WELLS K D, PRATHER R S. Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus. Nature Biotechnology, 2016, 34(1): 20-22.
[14] WHITWORTH K M, LEE K, BENNE J A, BEATON B P, SPATE L D, MURPHY S L, SAMUEL M S, MAO J, O'GORMAN C, WALTERS E M, MURPHY C N, DRIVER J, MILEHAM A, MCLAREN D, WELLS K D, PRATHER R S. Use of the CRISPR/Cas9 system to produce genetically engineered pigs from in vitro-derived oocytes and embryos. Biology of Reproduction, 2014, 91(3): 78.
[15] BURKARD C, LILLICO S G, REID E, JACKSON B, MILEHAM A J, AIT-ALI T, WHITELAW C B, ARCHIBALD A L. Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function. PLoS Pathogens, 2017, 13(2): e1006206.
[16] LI G, JIANG P, LI Y, WANG X, HUANG J, BAI J, CAO J, WU B, CHEN N, ZESHAN B.Inhibition of porcine reproductive and respiratory syndrome virus replication by adenovirus-mediated RNA interference both in porcine alveolar macrophages and swine. Antiviral Research, 2009, 82(3): 157-165.
[17] LU T, SONG Z, LI Q, LI Z, WANG M, LIU L, TIAN K, LI N. Overexpression of Histone deacetylase 6 enhances resistance to porcine reproductive and respiratory syndrome virus in pigs. PLoS One, 2017, 12(1): e0169317.
[18] CONG L, RAN F A, COX D, LIN S, BARRETTO R, HABIB N, HSU P D, WU X, JIANG W, MARRAFFINI L A, ZHANG F. Multiplex genome engineering using CRISPR/Cas systems. Science, 2013, 339(6121): 819-823.
[19] MIZUNO S, DINH T T, KATO K, MIZUNO-IIJIMA S, TANIMOTO Y, DAITOKU Y, HOSHINO Y, IKAWA M, TAKAHASHI S, SUGIYAMA F, YAGAMI K. Simple generation of albino C57BL/6J mice with G291T mutation in the tyrosinase gene by the CRISPR/ Cas9 system. Mammalian Genome, 2014, 25(7-8): 327-334.
[20] WANG H, YANG H, SHIVALILA C S, DAWLATY M M, CHENG A W, ZHANG F, JAENISCH R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell, 2013, 153(4): 910-918.
[21] FUJIHARA Y, IKAWA M. CRISPR/Cas9-based genome editing in mice by single plasmid injection. Methods in Enzymology, 2014, 546: 319-336.
[22] GUAN Y, SHAO Y, LI D, LIU M. Generation of site-specific mutations in the rat genome via CRISPR/Cas9. Methods in Enzymology, 2014, 546: 297-317.
[23] HAI T, TENG F, GUO R, LI W, ZHOU Q. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Rresearch, 2014, 24(3): 372-375.
[24] RUAN J, LI H, XU K, WU T, WEI J, ZHOU R, LIU Z, MU Y, YANG S, OUYANG H, CHEN-TSAI R Y, LI K. Highly efficient CRISPR/ Cas9-mediated transgene knockin at the H11 locus in pigs. Scientific Reports, 2015, 5(14253).
[25] HUANG L, HUA Z, XIAO H, CHENG Y, XU K, GAO Q, XIA Y, LIU Y, ZHANG X, ZHENG X, MU Y, LI K. CRISPR-Cas9-mediated ApoE-/- and LDLR-/- double gene knockout in pigs elevates serum LDL-C and TC levels. Oncotarget, 2017, 8(23): 37751-37760.
[26] WEHNES C A, REHBERGER T G, BARRANGOU R, SMITH A H. Short communication: determination of salmonella clustered regularly interspaced short palindromic repeats (CRISPR) diversity on dairy farms in Wisconsin and Minnesota. Journal of Dairy Science, 2014, 97(10): 6370-6377.
[27] GAO Y, WU H, WANG Y, LIU X, CHEN L, LI Q, CUI C, LIU X, ZHANG J, ZHANG Y. Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects. Genome Biology, 2017, 18(1): 13.
[28] CRISPO M, MULET A P, TESSON L, BARRERA N, CUADRO F, DOS SANTOS-NETO P C, NGUYEN T H, CRENEGUY A, BRUSSELLE L, ANEGON I, MENCHACA A. Efficient generation of myostatin knock-out sheep using CRISPR/Cas9 technology and microinjection into zygotes. PLoS One, 2015, 10(8):e0136695.
[29] KANG Y, ZHENG B, SHEN B, CHEN Y, WANG L, WANG J, NIU Y, CUI Y, ZHOU J, WANG H, GUO X, HU B, ZHOU Q, SHA J, JI W, HUANG X. CRISPR/Cas9-mediated Dax1 knockout in the monkey recapitulates human AHC-HH. Human Molecular Genetics, 2015, 24(25): 7255-7264.
[30] VARSHNEY G K, PEI W, LAFAVE M C, IDOL J, XU L, GALLARDO V, CARRINGTON B, BISHOP K, JONES M, LI M, HARPER U, HUANG S C, PRAKASH A, CHEN W, SOOD R, LEDIN J, BURGESS S M. High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9. Genome Research, 2015, 25(7): 1030-1042.
[31] GRATZ S J, UKKEN F P, RUBINSTEIN C D, THIEDE G, DONOHUE L K, CUMMINGS A M, O'CONNOR-GILES K M. Highly specific and efficient CRISPR/Cas9-catalyzed homology- directed repair in Drosophila. Genetics, 2014, 196(4): 961-971.
[32] ZHENG J, JIA H, ZHENG Y. Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9. International Journal for Parasitology, 2015, 45(2-3): 141-148.
[33] BARRANGOU R, DOUDNA J A. Applications of CRISPR technologies in research and beyond. Nature biotechnology, 2016, 34(9): 933-941. |